13 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
payors, and others in the medical community necessary for commercial success
If we are unable to obtain and maintain intellectual property protection … of our product candidates from physicians, health care payers, patients, and the medical community;
create positive publicity surrounding our product
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
to the broader research community, Licensee shall use reasonable efforts to publish or otherwise cause to be publicly disseminated within the research … community such scientific findings and results, together with the underlying data, provided that such results have been produced and verified
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
by physicians, patients, third-party payors, and others in the medical community necessary for commercial success.
If we are unable to obtain and maintain … of our product candidates from physicians, health care payers, patients, and the medical community;
create positive publicity surrounding our product
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
in the medical community necessary for commercial success.
If we are unable to obtain and maintain intellectual property protection for our technology … candidates from physicians, health care payers, patients, and the medical community;
create positive publicity surrounding our product candidates;
manage our
S-1
EX-99.5
069bj 1q38wkt5xnw5is
29 Jun 23
IPO registration
4:39pm
S-1
dl4zdb
29 Jun 23
IPO registration
4:39pm
DRS/A
h37el0eh2k
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
xudw4bcy3m5traeji4gp
2 May 23
Draft registration statement (amended)
12:00am
DRS
kkp44e1t9 e5kemi1
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next